摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氯-4-氟苯肼 | 84282-78-0

中文名称
3-氯-4-氟苯肼
中文别名
——
英文名称
3-chloro-4-fluorophenyl hydrazine
英文别名
3-Chloro-4-fluorophenylhydrazine;(3-chloro-4-fluorophenyl)hydrazine
3-氯-4-氟苯肼化学式
CAS
84282-78-0
化学式
C6H6ClFN2
mdl
——
分子量
160.578
InChiKey
DUORBNTWCCJANU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    74-79 °C (lit.)
  • 沸点:
    253.1±30.0 °C(Predicted)
  • 密度:
    1.430±0.06 g/cm3(Predicted)
  • 稳定性/保质期:
    按规定使用和贮存的这些物质不会分解,并且能够避免与氧化物接触。

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    38
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT-HARMFUL, KEEP COLD
  • 危险品标志:
    Xn
  • 安全说明:
    S26
  • 危险类别码:
    R22,R20/21/22,R36/37/38
  • WGK Germany:
    3
  • 海关编码:
    2928000090
  • 包装等级:
    III
  • 危险标志:
    GHS05,GHS06
  • 危险品运输编号:
    UN 2811 6.1/PG 3
  • 危险性描述:
    H301,H315,H318,H335
  • 危险性防范说明:
    P261,P280,P301 + P310,P305 + P351 + P338
  • 储存条件:
    存放于密闭、阴凉、干燥处

SDS

SDS:fe68e0dfcc6be9390eb9f91c2a4f83db
查看
Name: 1-(3-Chloro-4-fluorophenyl)hydrazine tech Material Safety Data Sheet
Synonym:
CAS: 84282-78-0
Section 1 - Chemical Product MSDS Name:1-(3-Chloro-4-fluorophenyl)hydrazine tech Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
84282-78-0 1-(3-Chloro-4-fluorophenyl)hydrazine unlisted
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 84282-78-0: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 74 - 76 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C6H6ClFN2
Molecular Weight: 161

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, acids, acid chlorides.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, carbon dioxide, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 84282-78-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-(3-Chloro-4-fluorophenyl)hydrazine - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 84282-78-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 84282-78-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 84282-78-0 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    3-氯-4-氟苯胺 3-chloro-4-fluorophenylamine 367-21-5 C6H5ClFN 145.564
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    —— (Z)-1-(3-chloro-4-fluorophenyl)-2-(oct-2-yn-1-ylidene)-hydrazine 1342638-48-5 C14H16ClFN2 266.746
    2-(3-氯-4-氟苯基)肼羧酸乙酯 2-(3-chloro-4-fluorophenyl)hydrazinecarboxylic acid ethyl ester 84304-75-6 C9H10ClFN2O2 232.642
    —— tert-butyl 2-(3-chloro-4-fluorophenyl)hydrazinecarboxylate 1513850-04-8 C11H14ClFN2O2 260.696
    —— (Z)-1-(3-chloro-4-fluorophenyl)-2-(3-phenylprop-2-yn-1-ylidene)hydrazine 1342638-40-7 C15H10ClFN2 272.709
    —— (Z)-1-(3-chloro-4-fluorophenyl)-2-(3-(p-tolyl)prop-2-yn-1-ylidene)hydrazine 1318807-98-5 C16H12ClFN2 286.736
    —— Ethyl pyruvate 3-chloro-4-fluorophenylhydrazone 473258-19-4 C11H12ClFN2O2 258.68
    —— (Z)-1-(3-chloro-4-fluorophenyl)-2-(4-phenylbut-3-yn-2-ylidene)hydrazine 1318808-03-5 C16H12ClFN2 286.736
    —— phenyl N-(3-chloro-4-fluoroanilino)carbamate 84304-77-8 C13H10ClFN2O2 280.686

反应信息

  • 作为反应物:
    描述:
    3-氯-4-氟苯肼吡啶盐酸羟胺 、 copper(II) sulfate 、 溶剂黄146 、 sodium hydroxide 作用下, 以 乙醇 为溶剂, 反应 3.5h, 生成 2-(3-chloro-4-fluorophenyl)-2H-1,2,3-triazole N-oxide
    参考文献:
    名称:
    1,2,3-三唑N-氧化物的位点选择性直接芳基化
    摘要:
    通过 2-芳基-1,2,3-三唑 N-氧化物与 Ar-X [X = Br, I 和B(OH)2]进行说明。该反应通过 Pd 催化的 C-H 键活化进行,并研究了芳基卤化物对反应性的影响。
    DOI:
    10.1002/ejoc.201300747
  • 作为产物:
    描述:
    3-chloro-4-fluorobenzenediazonium tetrafluoroborate 在 borohydride exchange resin 作用下, 以 甲醇 为溶剂, 以69%的产率得到3-氯-4-氟苯肼
    参考文献:
    名称:
    Selective Reduction of Aryl Diazonium Fluoroborates1
    摘要:
    Substituted aryl diazonium fluoroborates have been selectively reduced to the corresponding phenylhydrazines by using borohydride exchange resin (EER).
    DOI:
    10.1080/00397919708003336
点击查看最新优质反应信息

文献信息

  • PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
    申请人:Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
    公开号:US20200247815A1
    公开(公告)日:2020-08-06
    The present invention relates to pyrazolyl-containing tricyclic derivative, a preparation method therefor and the use thereof. In particular, the present invention relates to a compound as shown in the general formula (I), a preparation method therefor and a pharmaceutical composition containing the compound, and the use thereof as a protease such as ERK (MAPK) inhibitor in the treatment of cancers, bone diseases, inflammatory diseases, immunological diseases, nervous system diseases, metabolic diseases, respiratory diseases and heart diseases, wherein the definition of each substituent in the general formula (1) is the same as defined in the description.
    本发明涉及吡唑基含有的三环衍生物,其制备方法及其用途。具体而言,本发明涉及一种如通式(I)所示的化合物,其制备方法及含有该化合物的药物组合物,以及将其用作蛋白酶,如ERK(MAPK)抑制剂,用于治疗癌症、骨疾病、炎症性疾病、免疫疾病、神经系统疾病、代谢性疾病、呼吸系统疾病和心脏疾病,其中通式(1)中每个取代基的定义与描述中定义的相同。
  • [EN] NEW CRTh2 ANTAGONISTS<br/>[FR] NOUVEAUX ANTAGONISTES DE CRTH2
    申请人:ALMIRALL SA
    公开号:WO2013010881A1
    公开(公告)日:2013-01-24
    The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.
    本发明涉及公式(I)的化合物,制备此类化合物的方法以及它们在治疗可通过CRTh2拮抗剂活性改善的病理状况或疾病中的用途。
  • Unprecedented Direct Conversion of N-N and N=N bonds to N-(tert-Butyloxy)-carbamates
    作者:S. Chandrasekhar、Ch. Raji Reddy、R. Jagadeeshwar Rao
    DOI:10.1055/s-2001-17439
    日期:——
    For the first time a one step direct conversion of aromatic hydrazines and azo compounds to N-(tert-butoxycarbonyl) amines is achieved via reductive cleavage of N-N and N=N bonds using the inexpensive and safe hydride source polymethylhydrosiloxane (PMHS) and di-tert-butyl dicarbonate [(Boc)2O] in the presence of a catalytic amount of 10% Pd-C.
    首次通过使用廉价且安全的氢化物源聚甲基氢硅氧烷(PMHS)与二叔丁基二碳酸酯[(Boc)2O],在10% Pd-C催化剂的催化作用下,实现了芳香肼和偶氮化合物通过还原断裂N-N与N=N键,一步直接转化为N-(叔丁氧羰基)胺。
  • Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-Staphylococcus aureus Agents
    作者:Rawan Alnufaie、Hansa Raj KC、Nickolas Alsup、Jedidiah Whitt、Steven Andrew Chambers、David Gilmore、Mohammad A. Alam
    DOI:10.3390/molecules25122758
    日期:——
    In this paper, synthesis and antimicrobial studies of 31 novel coumarin-substituted pyrazole derivatives are reported. Some of these compounds have shown potent activity against methicillin-resistant Staphylococcus aureus (MRSA) with minimum inhibitory concentration (MIC) as low as 3.125 µg/mL. These molecules are equally potent at inhibiting the development of MRSA biofilm and the destruction of preformed
    本文报道了 31 种新型香豆素取代吡唑衍生物的合成和抗菌研究。其中一些化合物已显示出对耐甲氧西林金黄色葡萄球菌 (MRSA) 的有效活性,最低抑菌浓度 (MIC) 低至 3.125 µg/mL。这些分子在抑制 MRSA 生物膜的发展和预先形成的生物膜的破坏方面同样有效。这些结果非常重要,因为 MRSA 菌株已成为人类最具威胁的病原体之一,并且这种细菌在死亡率方面正在绕过 HIV。
  • Flow and batch mode focused microwave synthesis of 5-amino-4-cyanopyrazoles and their further conversion to 4-aminopyrazolopyrimidines
    作者:Catherine J. Smith、Francisco Javier Iglesias-Sigüenza、Ian R. Baxendale、Steven V. Ley
    DOI:10.1039/b709043a
    日期:——
    A new approach to the synthesis of 5-amino-4-cyanopyrazoles has been developed, utilising a novel flow microwave device. These products are then converted by a batch mode microwave process to structurally more complex dimeric and ‘mixed’ pyrazolopyrimidine structures.
    一种合成5-氨基-4-氰基吡唑的新方法已被开发出来,该方法采用了一种新颖的流动微波装置。这些产品随后通过批量模式微波工艺被转化为结构更为复杂的二聚体和“混合”吡唑并嘧啶结构。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐